Furthermore, obesity promotes an imbalance between glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2), impairing the incretin axis, which contributes to the appearance of insulin resistance; therefore, this whole process becomes involved in a vicious cycle [3]. Here, INS is linked to Obesity.